Research output per year
Research output per year
Personal profile
Research interests
Leukemia, stem cell mobilization, glioblastoma
Clinical interests
Leukemia, MDS, brain tumors, melanoma oncology
Fingerprint
Dive into the research topics where George Ansstas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Mehnert, J. M., Mitchell, T. C., Huang, A. C., Aleman, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L., Carberry, M., Frey, N., Kossenkov, A., Groisberg, R., Hernandez-Aya, L. F., Ansstas, G., Silk, A. W., Chandra, S., Sosman, J. A., Gimotty, P. A. & 2 others, , Mar 15 2022, In: Clinical Cancer Research. 28, 6, p. 1098-1106 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy
Helmink, B. A., Ansstas, G. & Fields, R., Mar 2022, In: Annals of Surgical Oncology. 29, 3, p. 1498-1501 4 p.Research output: Contribution to journal › Comment/debate
Open Access -
CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease
Heidari, F., Ansstas, G. & Ajamian, F., May 1 2022, In: Gerontology. 68, 4, p. 421-430 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab
Hwang, H., Huang, J., Khaddour, K., Butt, O. H., Ansstas, G., Chen, J., Katumba, R. G. N., Kim, A., Leuthardt, E. C. & Campian, J., Mar 2022, In: CNS oncology. 11, 1, CNS81.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
Khaddour, K., Johanns, T. M. & Ansstas, G., Jun 2021, In: Melanoma Management. 8, 2, 0022.Research output: Contribution to journal › Article › peer-review
Open Access